Federico Seragnoli
Psychotherapist in training; PhD student; psychedelic-assisted psychotherapy researcher
Data updated
Research Footprint
Federico Seragnoli appears in 6 tracked papers (2023–2026), most studied alongside LSD, MDMA and Psilocybin, across Depressive Disorders, Anxiety Disorders and PTSD.
Most-cited paper: Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies (35 citations).
Frequent co-authors: Gregor Hasler, Katrin Preller and Helena Aicher.
Background & Research
Federico Seragnoli is a psychotherapist in training working in the psychedelic unit of Geneva University Hospitals (HUG). He is also pursuing a PhD at the University of Lausanne, where his research focuses on metacognition and integration processes in psychedelic-assisted psychotherapy. His publications span clinical practice surveys, case reports, and reviews on psychedelic safety and therapeutic factors.
Key Impact
He is a Swiss psychedelic-assisted psychotherapy researcher and clinician whose work appears across multiple papers on clinical practice, adverse effects, and psychosis/mania risk.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →